NCT05878067View on ClinicalTrials.gov

A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 27, 2023

Primary Completion Date

October 6, 2023

Study Completion Date

October 6, 2023

Conditions
Dry Eye Syndrome
Interventions
DRUG

ABBV-444

Lubricant Eye drops

Trial Locations (1)

91702

Canyon City Eyecare /ID# 253652, Azusa

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY